ANI Pharmaceuticals | Umsatzkosten



Cost Of Sales Veränderung Datum
AbbVie USD 4.4B 184M 2024-12
ANI Pharmaceuticals USD 80.28M 68.05M 2024-12
Aurora Cannabis CAD 78.85M 891K 2024-12
Canopy Growth CAD 50.66M 9.51M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Hikma Pharmaceutical USD 813M 39M 2024-06
Knight Therapeutics CAD 47.25M 990K 2024-09
Novartis USD 3.31B 73M 2024-12
Perrigo USD 752.4M 69.3M 2024-12
Sun Pharmaceuticals INR 27.41B 463.4M 2024-12
Teva Pharmaceutical Industries USD 2.11B 18M 2024-12



ANI Pharmaceuticals Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.